4.6 Article

Early-Life Gut Bacteria Associate with IL-4-, IL-10-and IFN-γ Production at Two Years of Age

期刊

PLOS ONE
卷 7, 期 11, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0049315

关键词

-

资金

  1. Swedish Research Council [57X-15160-05-2, 57X-15160-07-3]
  2. Swedish Asthma and Allergy Associations' Research Foundation
  3. Cancer and Allergy foundation
  4. Swedish Association for Allergology
  5. Mjolkdroppen foundation
  6. Ragnar Soderberg- foundation
  7. Magnus Bergvall- foundation
  8. Konsul Th C Bergh foundation

向作者/读者索取更多资源

Microbial exposure early in life influences immune maturation and potentially also the development of immune-mediated disease. Here we studied early-life gut colonization in relation to cytokine responses at two years of age. Fecal samples were collected from infants during the first two months of life. DNA was extracted from the fecal samples and Bifidobacterium (B.) adolescentis, B. breve, B. bifidum, a group of lactobacilli (L. casei, L. paracasei and L. rhamnosus) as well as Staphylococcus (S.) aureus were detected with real time PCR. Peripheral mononuclear cells were stimulated with phytohaemagglutinin (PHA) and numbers of IL-4-, IL-10- and IFN-gamma secreting cells were evaluated using ELISpot. We further stimulated peripheral blood mononuclear cells with bacterial supernatants in vitro and assessed the IL-4-, IL-10- and IFN-gamma inducing capacity by flow cytometry and ELISA. Early S. aureus colonization associated with higher numbers of IL-4- (p = 0.022) and IL-10 (p = 0.016) producing cells at two years of age. In contrast to colonization with S. aureus alone, co-colonization with lactobacilli associated with suppression of IL-4- (p = 0.004), IL-10- (p = 0.004) and IFN-gamma (p = 0.034) secreting cells. In vitro stimulations of mononuclear cells with bacterial supernatants supported a suppressive role of L. rhamnosus GG on S. aureus-induced cytokine responses. We demonstrate that the early gut colonization pattern associates with the PHA-induced cytokine profile at two years of age and our in vitro findings support that specific bacterial species influence the T helper cell subsets. This suggests that dysbiosis in the early microbiota may modulate the risk of developing inflammatory conditions like allergy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Rheumatology

Natural killer cells and type II interferon in Ro/SSA and La/SSB autoantibody-exposed newborns at risk of congenital heart block

Margarita Ivanchenko, Gudny Ella Thorlacius, Malin Hedlund, Vijole Ottosson, Lauro Meneghel, Sophia Bjorkander, Amina Ossoinak, Joanna Tingstrom, Katarina Bremme, Eva Sverremark-Ekstrom, Kristina Gemzell-Danielsson, Sven-Erik Sonesson, Karine Chemin, Marie Wahren-Herlenius

Summary: This study reveals altered immune cell profiles in anti-Ro/La+ mothers and neonates, with increased NK cell frequencies in exposed neonates. The presence of type I and II interferon footprints and upregulation of NK cell activating ligands in fetal cardiac cells after exposure to type I interferon suggest innate immune activation in neonates of anti-Ro/La+pregnancy, potentially contributing to the risk of CHB.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Article Gastroenterology & Hepatology

Limosilactobacillus reuteri and Lacticaseibacillus rhamnosus GG differentially affect gut microbes and metabolites in mice with Treg deficiency

Yuying Liu, Thomas K. Hoang, Christopher M. Taylor, Evelyn S. Park, Jasmin Freeborn, Meng Luo, Stefan Roos, J. Marc Rhoads

Summary: In the treatment of Treg-deficiency-induced autoimmunity, Limosilactobacillus reuteri DSM 17938 (LR) showed greater efficacy than Lacticaseibacillus rhamnosus GG (LGG). The study demonstrated that two different probiotics produce distinct signatures in the fecal microbial community in mice with Treg deficiency, but with many similarities in global plasma metabolites in general. However, there are strain-specific microbial products with different anti-inflammatory properties, reinforcing the concept that one size does not fit all in the treatment of autoimmune disease.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2021)

Article Biotechnology & Applied Microbiology

Genome-scale insights into the metabolic versatility of Limosilactobacillus reuteri

Hao Luo, Peishun Li, Hao Wang, Stefan Roos, Boyang Ji, Jens Nielsen

Summary: The metabolic features and diversities of Limosilactobacillus reuteri strains were systematically investigated using genome-scale metabolic models (GEMs). The reconstructed GEM of L. reuteri ATCC PTA 6475 contains 894 reactions and 726 metabolites linked to 622 metabolic genes, which can simulate growth and amino acids utilization. Comparison of GEMs for 35 L. reuteri strains identified potential metabolic products associated with host adaptation.

BMC BIOTECHNOLOGY (2021)

Article Cell Biology

Activation of human γδ T cells and NK cells by Staphylococcal enterotoxins requires both monocytes and conventional T cells

Manuel Mata Forsberg, Claudia Arasa, Willemien van Zwol, Sibel Uzuncayir, Anna Schonbichler, Paulina Regenthal, Jenny Schelin, Karin Lindkvist-Petersson, Sophia Bjorkander, Eva Sverremark-Ekstrom

Summary: Staphylococcal enterotoxins (SE) trigger the activation of MAIT, gamma delta T, and NK cells mainly by reducing IFN-gamma expression through neutralizing IL-12, while cytotoxicity remains unaffected. Responses of unconventional T cells and NK cells occur subsequent to conventional T cells, and SEA's ability to activate gamma delta T and NK cells is dependent on the presence of monocytes and alpha beta T cells. Additionally, SE induces a diminished and delayed cytokine response in infants, particularly within unconventional T and NK cell populations.

JOURNAL OF LEUKOCYTE BIOLOGY (2022)

Article Microbiology

Distinct B cell subsets in Peyer's patches convey probiotic effects by Limosilactobacillus reuteri

Hao-Yu Liu, Antoine Giraud, Cedric Seignez, David Ahl, Feilong Guo, John Sedin, Tomas Walden, Jee-Hwan Oh, Jan Peter van Pijkeren, Lena Holm, Stefan Roos, Stefan Bertilsson, Mia Phillipson

Summary: The study shows that oral administration of the probiotic bacterium Limosilactobacillus reuteri R2LC increases the numbers and effector functions of B cell subsets, leading to enhanced IgA production, altered intestinal microbiota, and protection against inflammation.

MICROBIOME (2021)

Article Pharmacology & Pharmacy

Accelerated Wound Healing in Minipigs by On-Site Production and Delivery of CXCL12 by Transformed Lactic Acid Bacteria

Emelie Ohnstedt, Hava Lofton Tomenius, Peter Frank, Stefan Roos, Evelina Vagesjo, Mia Phillipson

Summary: Non-healing wounds are a growing medical problem that causes significant suffering. In this study, the topical administration of the drug candidate ILP100 proved to be safe and accelerated wound healing in minipigs, using different evaluation methods.

PHARMACEUTICS (2022)

Article Gastroenterology & Hepatology

Gut commensal Limosilactobacillus reuteri induces atypical memory-like phenotype in human dendritic cells in vitro

Gintare Lasaviciute, Myriam Barz, Marieke van der Heiden, Claudia Arasa, Kanwal Tariq, Jaclyn Quin, Ann-Kristin Ostlund Farrants, Eva Sverremark-Ekstrom

Summary: The secretome of the gut probiotic bacterium L. reuteri has an effect on memory responses in human immune cells, resulting in a secondary response phenotype different from other training agents. This has potential implications for therapeutic interventions targeting T cell responses.

GUT MICROBES (2022)

Article Immunology

Staphylococcus aureus-derived factors promote human Th9 cell polarization and enhance a transcriptional program associated with allergic inflammation

Isabella Badolati, Marieke van der Heiden, David Brodin, Marit Zuurveld, Szilvia Szilagyi, Sophia Bjorkander, Eva Sverremark-Ekstrom

Summary: In this study, it was found that Staphylococcus aureus enhances Th9 cell frequency and IL-9 secretion, which may contribute to the development of allergic diseases. Additionally, retinoic acid can suppress the Th9 responses induced by S. aureus and alter the gene expression associated with allergic inflammation. These findings highlight the importance of microbial and dietary factors in modulating Th9 cell polarization.

EUROPEAN JOURNAL OF IMMUNOLOGY (2023)

Article Microbiology

Extracellular membrane vesicles from Limosilactobacillus reuteri strengthen the intestinal epithelial integrity, modulate cytokine responses and antagonize activation of TRPV1

Yanhong Pang, Ludwig Ermann Lundberg, Manuel Mata Forsberg, David Ahl, Helena Bysell, Anton Pallin, Eva Sverremark-Ekstroem, Roger Karlsson, Hans Jonsson, Stefan Roos

Summary: Bacterial extracellular membrane vesicles (MV) are important mediators of microbe-host signals in host-pathogen interactions and interactions between mutualistic bacteria and their hosts. The study focused on MV derived from probiotics and found that they carry numerous bacterial cell surface proteins, some of which are involved in host-bacteria interactions. They can be internalized by epithelial cells, decrease leakage caused by enterotoxigenic Escherichia coli, regulate inflammatory responses in immune cells, and antagonize pain receptor channels. The findings have implications for the development of innovative and more efficient probiotic products.

FRONTIERS IN MICROBIOLOGY (2022)

Letter Allergy

Randomized controlled trial of slow peanut oral immunotherapy in young children: SmaChO study protocol

Carina Uhl, Eva Sverremark-Ekstrom, Magnus Borres, Motohiro Ebisawa, Erik Melen, Mika J. Makela, Jon R. Konradsen, Brian P. Vickery, Anna Asarnoj, Caroline Nilsson

CLINICAL AND EXPERIMENTAL ALLERGY (2023)

Article Microbiology

Antibiofilm activity and NMR-based metabolomic characterization of cell-free supernatant of Limosilactobacillus reuteri DSM 17938

Irene Vitale, Mattia Spano, Valentina Puca, Simone Carradori, Stefania Cesa, Beatrice Marinacci, Francesca Sisto, Stefan Roos, Gianfranco Grompone, Rossella Grande

Summary: This study evaluated the antibiofilm activity of cell-free supernatant (CFS) and its sub-fractions (SurE 10 K and SurE) produced by Limosilactobacillus reuteri DSM 17938 against biofilm-producing bacterial species. The results showed that CFS exhibited promising antibiofilm activity against biofilms formed by clinically relevant microorganisms. NMR metabolomic analysis identified and quantified several compounds, mainly organic acids and amino acids, with lactate being the most abundant metabolite in all samples. The storage stability of these postbiotics was evaluated using the CIEL*a*b parameters.

FRONTIERS IN MICROBIOLOGY (2023)

Article Medicine, General & Internal

Engineered bacteria to accelerate wound healing: an adaptive, randomised, double-blind, placebo-controlled, first-in-human phase 1 trial

Emelie Ohnstedt, Evelina Vagesjo, Andreas Fasth, Hava Lofton Tomenius, Pia Dahg, Sofia Jonsson, Nisha Tyagi, Mikael Astrom, Zhanar Myktybekova, Lovisa Ringstad, Margareth Jorvid, Peter Frank, Per Heden, Stefan Roos, Mia Phillipson

Summary: This study aimed to evaluate the safety and tolerability of ILP100-Topical drug in humans and investigate its clinical and biological effects on wound healing. The results showed that ILP100-Topical was safe and well-tolerated in all individuals and doses, and it accelerated wound healing and increased the density of CXCL12+ cells in the wounds.

ECLINICALMEDICINE (2023)

Article Biotechnology & Applied Microbiology

Metabolic engineering of human gut microbiome: Recent developments and future perspectives

Peishun Li, Stefan Roos, Hao Luo, Boyang Ji, Jens Nielsen

Summary: Many studies have shown the link between gut microbiota and human health and disease. Manipulation of gut microbiota, such as supplementation of probiotics, has been suggested as a feasible method, but with limited therapeutic efficacy. In order to develop effective microbiota-targeted diagnostic and therapeutic strategies, metabolic engineering has been applied to construct genetically modified probiotics and synthetic microbial consortia.

METABOLIC ENGINEERING (2023)

Article Biotechnology & Applied Microbiology

Genomic, phenotypic, and clinical safety of Limosilactobacillus reuteri ATCC PTA 4659

Malin Sendelius, Jakob Axelsson, Peidi Liu, Stefan Roos

Summary: This study conducted a systematic safety assessment of Limosilactobacillus reuteri ATCC PTA 4659 through genome analysis, phenotypic characterization, and a human clinical safety study. The results showed that the strain is susceptible to antibiotics and does not possess virulence or antibiotic resistance genes. It was also found to have a high adhesion to mucus and tolerance to gastric pH and bile, indicating its potential as a probiotic strain. The human clinical safety study demonstrated that the strain is safe for human consumption.

JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY (2023)

暂无数据